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Abstract. In article is narrated about Thymosin β4. Its structure, a number of strategically 
important properties and opportunities is described. The list of researches and achievements 
over the past few years of researches is provided. On the basis of its multipurpose activities 
during regeneration of fabrics in various experiments on animals, Thymosin β4 has the 
potential for new researches, in kidneys and a liver, and also recovery of a spinal cord, bones 
and injury of ligaments. Besides, it can be useful in case of treatment of a wide range of other 
diseases, including concerning consequences of old bacterial damages and viral infections.  
Keywords: Thymosin β4, reparation, traumatism. 
 
Today injury rate level constantly grows. Thanks to access to extreme sports, fixed haste, to emergencies 
people often are traumatized, both household, and production: whether it is small defect of integuments or 
extensive combined injury. Violation of healing of wounds is a problem for the immobilized patients sick with 
diabetes, and also elderly people. According to RosStat for 2015-2016 the registered surplus, both a 
production, and household injury rate on 1000 people – 92.2 persons, i.e. nearly 10% is observed. The surgery, 
orthopedics, traumatology is engaged in their diagnostics and treatment. For treatment and rehabilitation of 
patients a number of medicines such as is used: analgetic preparations, antihistaminic preparations, antibiotics, 
hormonal preparations, calcium preparations, vascular preparations, spazmolitik, locally – ointments. In case 
of inefficiency of conservative treatment resort to surgical. Now creation of the reparation preparation 
possessing a high reparative capability is very actual task for modern medicine and pharmacology as there is a 
great demand which becomes covered only for 40%.  
Proceeding from statistical data of the authoritative medical Pubmed portal (Figure) it is visible that every 
year scientists show the increasing interest concerning a Thymosin β4 (Tβ4).  
In spite of the fact that interest in studying of properties and structure of a Tβ4 has arisen 30 years ago – only 
the small part of properties of this peptide is studied. It proves a number of several experiments which are already 
made diversely and systems (Table 1). 
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Figure. Chronology of the publication on the subject Tβ4 
Table 1 
Some researches of properties of peptide of Tβ4 
Тβ4 
AUTHORS SUBJECT RESULT 
Gabriel Sosne, George W Ousler Tβ4 ophthalmologic solution for a dry eye. 
(randomized, placebo – controlled, the phase II 
of clinical trials, is carried out with use of 
controlled medium) (CAE ™). 
This research confirms efficiency of 
0,1% of Tβ4 as topical treatment for 
simpli-fication of signs and symptoms 
of a dry eye. The therapeutic window of 
safety is defined. 
Tian-JiaoXu , Qi Wang 
Xiao-Wen Ma, Zhen ZhangWei 
Zhang, Xiao-Chang Xue, Cun 
Zhang, QiangHao, Wei-Na Li, 
Ying-Qi Zhang Meng Li 
Tβ4 represents a peptide from 43 
amino acids. Has crucial importan-ce for 
restoration and reconstruction of tissues of a skin, 
eyes, heart and a nervous system after a trauma. 
Fully to use the efficiency as an agent for 
treatment of the disease caused by a trauma it is 
recommended to spread out it to dimeasures. 
Dimeasures of Tβ4 render a 
superactivity on an adhesion of 
wounds, than native Tβ4. Process of 
cleaning is simple and very effective 
with the smallest expenses. 
Ildiko Bock-Marquette, Ankur 
Saxena, Michael D. White 
Tβ4 activates the integrin-sewed kinases and 
activates migration of stem cells in heart, 
thereby increases survival of cardiomyocy-tes 
and restoration of normal work of heart. 
Participation of Tβ4 in migration of cells 
and survival of cardiomyocytes at distur-
bance of a circulation in heart, them 
redistribution is mini-mized by losses of 
cardio-myocytes later myocar-
dialinfarction. 
Yue Zhou, Eliana Martinez, Li-
Ping Su, Kok-Onn Lee1, Lei Ye  
Tβ4 stimulates an angiogenesis and enlarges a 
pool of cells precursors of muscles at ischemic 
option of sceletal muscles in model of an 
ischemia of back extremities of a mouse  
Now research proved that Tβ4 makes 
direct impact on neovascularization and 
neo-genesis of sceletal muscles in model 
of an ischemia of a back extremity of a 
mouse. Tβ4 considerably enlarged density 
of capillaries. It is bound to its biological 
function on endothelial cells: migrations of 
endothelial cells and their proliferation. 
Deborah Philp, 
MahnazBadamchian, Brooke 
Scheremeta, Mychi Nguyen, Allan 
L. Goldstein, Hynda K. Kleinman 
Tβ4 – the synthetic peptide containingits actin 
– the binding domain promote a fast adhesion
of dermal defect. 
It is proved on experimental model at 
mice with a diabetes mellitus and old 
mice. 
 Martynov M.A., Martynova O.V., Shkileva I.Y., Tokarev I.A., Dovgan A.N. Thymosin β4 as 
basis for creation of a reparation preparation of new generation. Research result: 
pharmacology and clinical pharmacology. Vol. 2, №3 (2016): 101-106. 
103 
 
RESEARCH RESULT:  
PHARMACOLOGY AND CLINICAL PHARMACOLOGY 
In this article we will consider Thymosin 
derivatives β4 which can be a basis for creation of 
modern and innovative reparation drug and a 
vasoprotective. 
Adhesion of wounds includes several stages:  
1) inflammation (hemostases / vasoconstrictions),  
2) proliferation (angiogenesis or vasifaction) and  
3) migration of keratinotsit and remodeling (collagen 
adjournment). 
Tβ4 represent family of highly conservative 
polar peptides with a molecular weight of 5kd. One 
of representatives of this family Tβ4. It consists of 43 
amino acids and the 4964th dalton has molecular 
weight [1, 2]. With the N-trailer acetylated rest of a 
serine. Тβ4 is a larger water-soluble peptide which 
was for the first time allocated in 1966 by scientists 
Goldstein and Whyte from a bull tissue of a thymus. 
Researches in the field of hormones of a thymus led 
to a conclusion that Thymosin beta contain 
practically in all tissues and various cells of a human 
body except for erythrocytes. High concentration 
were noted in a lien, a thymus, mild and peritoneal 
macrophages, and also in thrombocytes, a blood 
plasma, a wound exsudate. After a skin trauma, the 
high Tβ4 levels naturally are present (13 mkg/ml) at 
wound liquid [3, 4]. He also acts as the main 
molecule of a complexing  actin in all eukaryotic 
cells and is the potent regulator of an 
aktinapolimerization at mammals [5]. 
Thymosin β4 is bound to a G-actin, blocks an 
actin polymerization with a factor of XIIIa of 
thrombocytes, exerting a great influence on process 
of an adhesion of wounds [6, 7]. Two proteins 
supporting a G-actin pool (a monomeric actin) are 
Тβ4 and a pro-eagle owl. In turn, the G-actin, is the 
water-soluble globular protein (weight 42 000 dalton) 
consisting of 376 amino-acid remains. One molecule 
ATP is bound to each molecule of a G-actin. Тβ4 as 
well as pro-eagle owls – low-molecular proteins with 
a molecular mass of a 12-15kd. They accelerate ADF 
exchange mechanism for ATP, as well as Тβ4. 
Acting as the buffer, it binds a monomeric actin from 
where follows that it prevents polymerization the 
aktin of microfilaments for maintenance of the 
general pool the monomers of aktin for needs of a 
cell. Changes in Thymosin expression β4 are bound 
to a differentiation of cells, that is it is possible to 
assume what Тβ4 suppresses energy release, at the 
same time keeping a cytoskeleton, cellular structure 
and cellular mobility from destruction. Release of 
Thymosin from a complex with an actin and 
emergence it in a blood plasma, possessing a 
hypotoxicity and presence at rather high 
concentration at many types of cells of mammals, 
both at a cytoplasma, and at an extracellular 
environment. Tβ4 plays an important role in 
differentiation of stem cells in developments, and 
also activation of cells of precursors, induction of 
their migration, differentiation and integration in 
processes of an angenesis, in particular induction of a 
neoangiogenesis. Tβ4 can be the signal starting 
immune system, induction of a chemotaxis, inhibition 
of a proliferation of stem cells of marrow, inhibition 
of an inflammation, an important property of 
induction of a neoangiogenesis with the subsequent 
reparative neogenesis of organs and tissues. A series 
of the active centers in Tβ4 amino acids define the 
action on physiological processes [8, 9].   
Fragments in amino acid 1-4 have 
antiinflammatory properties, 1-15 antiapoptozny and 
cytoprotective effect and 17-23 an angiogenesis and 
growth of hair is active for migration of cells, binding 
by an actin, a dermal adhesion of wounds. Tβ4 
participates in a series of cellular reactions, such as an 
angiogenesis, an adhesion of wounds, body height of 
hair, an apoptosis and an inflammation [3, 10, 11, 12, 
13, 14]. It inhibits an inflammation, microbial body 
height, formation of the cicatrix (due to depression of 
level of miofibroblast) and an apoptosis, protects cells 
from cytotoxic damage, including glutamatneyronalny 
toxicity [1, 15, 16, 17, 18, 19].    
Тβ4 represents multipurpose protein which 
stimulates migration and a differentiation of stem 
cells, synthesis of a protease, and also an expression 
of various regulatory genes, such as laminin-332, a 
fibronectin, matrix metalproteases, factors of body 
height of hepatocytes and antioxidatic enzymes [11, 
18, 20, 21, 22, 23, 24, 25]. Migration of cells 
represents difficult process. Tβ4 promotes activity of 
matrix proteinases which is necessary for migration 
of epithelial cells [9, 26, 27, 28].     
Inhibitors of these enzymes reduce migration of 
various types of cells. Such enzymes also degrade and 
let out matrix molecules which can be hemotaktilny 
factors of migration, thereby Tβ4 promotes chemotactic 
migration of cells to the place of the damaged site 
 [6, 16, 26, 30, 31,32, 33]. Such type of epithelial 
migration has crucial importance for adhesion process. 
Migrations of Tβ4 it is carried out in several ways. 
Direct migration assumes ability of Tβ4 to bind an 
actin. Proteases promote and improve migration, way 
the chemotoxicity factors of a matrix and inhibition of 
receptors of adhesion. Tβ4 induces synthesis of 
laminin-332 which is important factors of adhesion and 
migration of cells. Other mechanism includes 
stabilization of a factor of a transcription of HIF1 which 
is bound to the laminin-332 pro-motor, its chains. 
Proteases also reduce production of laminin-332, 
generate smaller chemotoxicity activity. Laminin-332 
also stabilizes a complex: a cell and a cell matrix, their 
interaction which are important for migration of cells to 
the damaged site of tissues. Tβ4 possesses 
antiapoptichesky activity by conservation integral 
structure an epithelium for migration of a leaf. 
Martynov M.A., Martynova O.V., Shkileva I.Y., Tokarev I.A., Dovgan A.N. Thymosin β4 as 
basis for creation of a reparation preparation of new generation. Research result: 
pharmacology and clinical pharmacology. Vol. 2, №3 (2016): 101-106. 
104 
RESEARCH RESULT:  
PHARMACOLOGY AND CLINICAL PHARMACOLOGY 
Cosecreted thrombocyte Tβ4 in the field of the injured 
derma, can accelerate an adhesion of dermal wounds, 
promoting migration of cells, accelerating collagen 
adjournment, inhibiting both an inflammation and an 
apoptosis [34, 35]. Tβ4 reduces an inflammation in 
tissues after different types of injuries by depression of 
migration of inflammatory factors; now are defined at 
the molecular level [1, 16, 30, 38, 39]. This decrease of 
an inflammation in fabric defect promotes Tβ4-
mediated of a reparation and is important for this 
process, and also solves concrete actions for migration, 
Tβ4-mediated of cells for exercise of restoration of 
tissues. For example, Tβ4 reduces inflammatory factors, 
cytokines and chemokines in many tissues, also reduces 
inflammatory infiltration, activates anti-oxidizing 
enzymes, and reduces formation of active forms of 
oxygen. Тβ4 inhibits TNF-α- inducibility of a nuclear 
factor an activation kappa In and blocks the Rela / 
translocation of p65 and the sensitizing effects of the 
intracellular binding partners pinch-1 and integrin-
sewed kinazy.  
Тβ4 selektivno bridges tissue XIIIa factor 
transglutaminases for various molecules, including an 
actin, collagen, fibrin and a fibrinogen [39, 41]. Other 
molecules, such as a plasmin, alcohol dehydrogenase, 
a hexokinase, a pyruvatekinase, and a lactate 
dehydrogenase, can't be sewed Тβ4. Тβ4 it was 
identified as an angiogenic factor in the screen of the 
early genes induced during a differentiation of 
endothelial cells of invitro [42].   
Tβ4 the best conservation of cardiomyocytes is 
promoted after an ischemia, by effect which is mediated 
by rising of an expression of a factor of body height of 
an endothelium of vessels (VEGF) and activation 
integrina-sewed kinases (ILK) [29]. It is surprising that 
it is little-known about potential receptors. Considering 
purinoceptor alarm ways of the active centers it would 
be possible to expect several receptors [8]. A lot of 
things are also unknown of Tβ4 role in a core. After an 
incubation with cells, it quickly (in 30 minutes), is 
transported in a core where functions as a factor of a 
transcription [1, 43]. The arising data demonstrate to 
what recent researches showed, чтоTβ4 is superfluous 
expresses in malignant tumors, and was suggested that 
it is bound to metastatic ability and an angiogenesis [10, 
31, 44, 45, 46]. The induced expression of Tβ4 
strengthens body height of a tumor and an innidiation in 
cellular lines of a melanoma and fibrosarcoma of a 
mouse [47]. Besides, Tβ4 hyper expression in cancer 
cells of a large intestine of the person cause the 
strengthened body height and an invasion at 
transplantation these cancer cells of mice [46, 48]. It is 
proved what an excess expression of Tβ4 promoted 
penetration of cells and their migration through 
ILK/AKT/β katenina-of an alarm way, causing 
transition epithelial to mesenchymal cancer 
in  colorectal a blast. Tβ4 also works as the hypoxia 
regulator which controls migration of cancer cells to 
places of an angiogenesis and innidiation of a tumor 
[49]. These various cellular answers are regulated by 
Tβ4-опосредованной of an expression of several 
genes, such as specific proteases, laminin-5, and several 
inflammatory cytokines and chemokines. Tβ4 the beta 
(TGF beta) in the cultivated cornea cells strengthens an 
expression of laminin-5 and the transforming body 
height factor that in turn increases the activity of 
laminin-5 and TGF-β- induced of migration of cells and 
synthesis of a collagen, respectively [14]. 
Tβ4 influences alarm ways of Want by an 
activation regulation a glycogen – synthase – 
kinases-3 (GSK-3) in migration of cells of a 
carcinoma of the stomach [50].  
The factor of body height of hepatocytes (HGF) 
promotes rising a regulation of Tβ4 which influences 
a wound repair in endothelial cells of an umbilical 
vein of the person [51].  
 Тβ4 promotes a full normal adhesion of all 
surface of a dermal wound at steroid treatment at 
animals with a diabetes mellitus [1, 41, 43]. Tβ4 also 
activly restores and regenerates tissues of an eye, 
heart, a brain, a peripheric nervous system and a 
spinal cord and stimulates an angiogenesis in some 
tissues at systemic use, but not at local use on a 
wounded surface of an eye.  
Two independent randomized double blind people 
clinical tests proved that experimental gel in structure 
with Tβ4 accelerates a dermal adhesion. Uses of Tβ4 in 
treatment of other diseases caused by a trauma such as a 
myocardial infarction or reperfusion damage trauma 
corneas, and an ischemia of a brain induces migration 
of cells to the place of damage [1, 6, 15, 16, 18, 41,]. It 
was revealed that Тβ4 in any phosphatic and buffer 
saline solution or hydrogel activly accelerates dermal an 
adhesion of wounds at healthy rats. At the mice sick 
with Diabetum where the slowed-down adhesion, was 
revealed that adjournment of a collagen were much 
lower, than at the mice receiving Tβ4 as well as in any 
phosphatic and saline buffered solution or hydrogel. No 
differences were observed in migration of keratinotsit, 
at all animals with Diabetum, showing almost full 
wound repair for the 8th day. These researches show 
that Tβ4 is active for an adhesion of wounds in models 
of disturbance of an adhesion and can be effective the 
relation of chronic diseases at the person. 
Тβ4 participate in activation the  multipotent of 
cells precursors, integration of new cells at the place of 
a lesion and formation of their microvascular niche, 
increases neogenesis. Neogenesis of any tissue it isn't 
possible without a full-fledged neoangiogenesis. For 
this reason development and creation of the drugs 
activating a neoangiogenesis and possessing 
endotelioprotektivny properties is one of the main tasks 
of modern pharmacology and medicine in general. 
Several additional biological activities were identified, 
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but not localized in a molecule, including its 
antimicrobic activity, induction of different genes 
(including laminin-5, MMP, TGF a beta, a terminal 
dezoksinukleotidiltransferaza and the proteins 
connected to angiogenesis), and ability to activate 
ILK/Pinch/Akt and other signal molecules important in 
ways of apoptosis and inflammatory ways. Biological 
activity of Tβ4, is defined by the active centers in short 
peptide sequences. 
Thus, as Tβ4 renders a wide range of functions, 
interacting with different molecules, it is important to 
research as Tβ4 is regulated to understand the 
mechanism of action Tβ4. 
On the basis of its multifunction activities during 
regeneration of fabrics in different experiments on 
animals, Tβ4 has the potential for new researches, in 
kidneys and a liver, and also restoration of a spinal cord, 
bones and injury of ligaments. Besides, it can be useful 
in case of treatment of a wide range of other diseases, 
including concerning consequences of old bacterial 
damages and viral infections.  
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